References

Divyapriya GK, Yavagal PC, Veeresh DJ. Casein phosphopeptide–amorphous calcium phosphate in dentistry: an update. Int J Oral Health Sci. 2016; 6:18-25
Cochrane NJ, Reynolds EC. Calcium phosphopeptides – mechanisms of action and evi-dence for clinical efficacy. Adv Dent Res. 2012; 24:41-47
Yengopal V, Mickenautsch S. Caries preventive effect of casein phosphopeptide-amorphous calcium phosphate (CPP–ACP): a meta analysis. Acta Odontol Scand. 2009; 67:321-332
Pitts NB, Zero DT, Marsh PD Dental caries. Nat Rev Dis Primers. 2017; 3:1-16
Public Health England. Oral health survey of five-year-old children 2017. 2018. https://www.gov.uk/government/statistics/oral-health-survey-of-5-year-old-children-2017 (accessed January 2021)
HSCIC. Hospital Episode Statistics England 2015-2016. 2016. https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2015-16 (accessed February 2021)
Morgan MV, Adams GG, Bailey DL The anticariogenic effect of sugar-free gum containing CPP–ACP nano complexes on approximate car-ies determined by digital bitewing radiography. Caries Res. 2008; 42:171-184
Raphael S, Blinkhorn A. Is there a place for Tooth Mousse® in the prevention and treatment of early dental caries? A systematic review. BMC Oral Health. 2015; 15
Li J, Xie X, Wang Y 8. Long-term remineralizing effect of casein phosphopeptide-amorphous calcium phosphate (CPP–ACP) on early caries lesions in vivo: a systematic review. J Dent. 2014; 42:769-777
Marinho VCC, Higgins J, Logan S, Sheiham A. Fluoride toothpastes for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2003; 1
Marinho VCC, Chong LY, Worthington HV, Walsh T. Fluoride mouthrinses for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2016; 7
Marinho VCC, Worthington HV, Walsh T, Clarkson JE. Fluoride varnishes for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2013; 7
Cochrane NJ, Saranathan S, Cai F Enamel subsurface lesion re-mineralisation with casein phosphopeptide stabilised solutions of calcium, phosphate and fluoride. Caries Res. 2008; 42:88-97
Srinivasan N, Kavitha M, Loganathan SC. Comparison of the remineralization potential of CPP–ACP and CPP–ACP with 900ppm fluoride on eroded human enamel: an in situ study. Arch Oral Bio. 2010; 55:541-544
Yan Z, Yuan H, Yiming C Efficacy of fluorides and CPP–ACP vs fluorides monotherapy on early caries lesions: a systematic review and meta-analysis. PLoS One. 2018; 13
Sudjalim TW, Woods MG, Manton DJ. Prevention of white spot lesions in orthodontic practice: a contemporary review. Aust Dent J. 2006; 51:284-289
Travess H, Roberts-Harry D, Sandy J. Orthodontics. Part 6: risks in orthodontic treatment. Br Dent J. 2004; 196:71-77
Julien K, Buschang P, Campbell P. Prevalence of white spot lesion formation during orthodontic treatment. Angle Orthod. 2013; 83:641-647
Craig S, Baker S, Rodd HD. How do children view other children who have visible enamel defects?. Int J Paediatr Dent. 2015; 25:399-408
Benson PE, Parkin N, Millett DT Fluorides for the prevention of white spots on teeth during fixed brace treatment. Cochrane Database Syst Rev. 2003; 3
Benson PE, Parkin N, Dyer F Fluorides for the prevention of early tooth decay (demineralised white lesions) during fixed brace treatment. Cochrane Database Syst Rev. 2013; 12
Bergstrand F, Twetman S. A review on prevention and treatment of post-orthodontic white spot lesions – evidence-based methods and emerging technologies. Open Dent J. 2011; 5:158-162
Chen H, Liu X, Dai J Effect of remineralising agents on white spot lesions after orthodontic treatment: a systematic review. Am J Orthod Dentofac Orthop. 2013; 143:376-382
Singh S, Singh S, Goyal A Effects of various remineralizing agents on the outcome of post-orthodontic white spot lesions (WSLs): a clinical trial. Prog Orthod. 2016; 17:1-8
Karabekiroğlu S, Ünlü N, Küçükyilmaz E Treatment of post-orthodontic white spot lesions with CPP–ACP paste: a three year follow up study. Dent Mat J. 2017; 36:791-797
Wallace A, Deery C. Management of opacities in children and adolescents. Dent Update. 2015; 42:951-958
Rees JS. The role of drinks in tooth surface loss. Dent Update. 2004; 31:318-326
Health and Social Care Information Centre. Child Dental Health Survey 2013, England, Wales and Northern Ireland. 2013. https://digital.nhs.uk/data-and-information/publications/statistical/children-s-dental-health-survey/child-dental-health-survey-2013-england-wales-and-northern-ireland (accessed January 2021)
Diagnosis, prevention and management of dental erosion. 2013. http://www.rcseng.ac.uk/-/media/files/rcs/fds/publications/dental-erosion-2013.pdf (accessed January 2021)
Manton D, Cai F, Yuan Y Effect of casein phosphopeptide–amorphous calcium phosphate added to acidic beverages on enamel erosion in vitro. Aust Dent J. 2010; 55:275-279
Piekarz C, Ranjitkar S, Hiunt D, McIntyre J. An in vitro assessment of the role of Tooth Mousse in preventing wine erosion. Aust Dent J. 2008; 53:22-25
Ramalingham L, Messer L, Reynolds E. Adding casein phosphopeptide–amorphous calcium phosphate to sports drinks to eliminate in vitro erosion. Pediatr Dent. 2005; 27:61-67
Rallan M, Chaudhary S, Goswami M Effect of various remineralising agents on human eroded enamel of primary teeth. Eur Arch Paediatr Dent. 2013; 14:313-318
Somali R, Jaidka S, Singh D, Arora V. Remineralizing potential of various agents on dental erosion. J Oral Biol Craniofac Res. 2014; 4:104-108
Weerheijm K. Molar incisor hypomineralization (MIH): clinical presentation, aetiology and management. Dent Update. 2004; 31:9-12
Madhavan S, Nayak M, Shenoy A Dentinal hypersensitivity: a comparative clinical evaluation of CPP–ACP F, sodium fluoride, propolis, and placebo. J Conserv Dent. 2012; 15:315-318
Poulsen S, Gjørup H, Haubek D Amelogenesis imperfecta – a systematic literature review of associated dental and oro-facial abnormalities and their impact on patients. Acta Odontol Scand. 2008; 66:193-199
West N, Seong J, Davies M. Management of dentine hypersensitivity: efficacy of professionally and self-administered agents. J Clin Periodontol. 2015; 42:S256-S302
Azarpazhooh A, Limeback H. Clinical efficacy of casein derivatives: a systematic review of the literature. J Am Dent Assoc. 2008; 139:915-924
Talioti E, Hill R, Gillam D. The efficacy of selected desensitizing OTC products: a systematic review. ISRN Dent. 2014;
Public Health England. Delivering better oral health: an evidence-based toolkit for prevention. 2017. http://www.gov.uk/government/publications/delivering-better-oral-health-an-evidence-based-toolkit-for-prevention (accessed January 2021)

Is there a role for casein phosphopeptide–amorphous calcium phosphate (cpp-acp) in paediatric dentistry?

From Volume 48, Issue 2, February 2021 | Pages 127-132

Authors

Claire Warner

BDS, MFDS RCPS(Glasg), PGCert MedEd, MClinDent, MPaedDent RCPS(Glasg)

Specialist in Paediatric Dentistry, Community Dental Services CIC, Derbyshire, UK

Articles by Claire Warner

Email Claire Warner

Helen J Rogers

BDS, MJDF RCS(Eng), PGDipConSed, MClinRes, MPaed Dent RCS(Eng)

Academic Clinical Fellow in Paediatric Dentistry, Unit of Oral Health and Development, School of Clinical Dentistry, University of Sheffield, Claremont Crescent, Sheffield, S10 2TA, UK.

Articles by Helen J Rogers

Abstract

In the age of minimally invasive dentistry, products with the ability to prevent and reverse common dental diseases are becoming increasingly popular. Casein phosphopeptide–amorphous calcium phosphate (CPP–ACP) contains the compounds casein, phosphate and calcium, which all have the ability to remineralize enamel. Dental caries, visible demineralization following removal of orthodontic appliances, non-carious tooth surface loss and dentine hypersensitivity due to structural anomalies are frequently seen in children and young people. The evidence for CPP–ACP and fluoride-containing CPP–ACP is positive for managing dental caries and non-carious tooth surface loss, specifically erosion, but is less clear in the management of visible demineralization following orthodontic appliance removal and dentine hypersensitivity owing to structural anomalies. When recommending CPP–ACP-containing products, dental practitioners should be aware of medical and social contra-indications that preclude its use.

CPD/Clinical Relevance: CPP–ACP may have a role in the management of common paediatric dental conditions.

Article

Casein phosphopeptide–amorphous calcium phosphate (CPP–ACP) is a calcium-based phosphate system that aids enamel remineralization through promoting apatite formation.1 The CPP–ACP complex (Recaldent) was developed at the School of Dental Science at the University of Melbourne, Victoria, Australia and is marketed in the UK as GC Tooth Mousse or GC MI Paste Plus, which also contains fluoride. A varnish containing both CPP–ACP and fluoride (GC MI varnish) is available, as is a glass ionomer cement with added CPP–ACP (GC Fuji VII EP, GC, Japan), although the latter is currently only available in Australia. Another formulation that incorporates Recaldent is chewing gum (available through BreezeCare UK online).

Calcium, phosphate and the protein casein, which are found in milk products, have the potential to remineralize enamel, but large volumes are required.1 CPP is formed when casein is digested by the enzyme trypsin, then aggregated with calcium phosphate and purified using ultrafiltration.2 While ACP has the potential to remineralize enamel, it is unstable and rapidly crystallizes out, promoting the formation of dental calculus. When CPP is combined with ACP, the multiple phosphoseryl residues from casein bound in CPP stabilize ACP by preventing its precipitation into a crystalline phase. The resulting CPP–ACP complex forms a stable remineralization compound.1

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available